SCHEDULE 13G

Company

CATALYST PHARMACEUTICALS, INC.

Filed

November 16, 2007

Accession Number

0000913849-07-000536

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →